LEYRE
CHASCO EGUILAZ
University of Paris-Sorbonne
París, FranciaUniversity of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2024
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
2022
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4